Dr. Abraham Palmer discusses caffeine on MPR News
Dr. Abraham Palmer joins the crew of “The Daily Circuit” on Minnesota Public Radio News to discuss caffeine, how it affects people and how it is marketed. A link to the show can be found here.
Dr. Abraham Palmer comments on caffeine in foods and beverages
In a report by Allison Aubrey on the NPR show “All Things Considered”, Dr. Abraham Palmer discuses new sources of caffeine in foods and beverages and how caffeine affects people differently. “There’s a lot of variation in the way people experience the effects of caffeine.” Click here to listen to the show and here to read an extended version.
Dr. Abraham Palmer and Clarissa Parker travel to ACNP in Hollywood, Florida
Clarissa received a prestigious travel award; Abraham was accompanied by Stephanie Dulawa, his wife (they are both Associate Members) and Ariela, his 3 year old daughter. It was Ariela’s 3rd time at ACNP, meaning that she is among the few people who can honestly say that they’ve never missed ACNP.
Amy Hart’s article: “Candidate gene studies of a promising intermediate phenotype: failure to replicate” accepted for publication in Neuropsychopharmacology
Amy’s article: “Candidate gene studies of a promising intermediate phenotype: failure to replicate” has been accepted for publication in Neuropsychopharmacology. You can find the full article here.
Camron Bryant leaves for Boston
Camron leaves the lab to start his new job in Boston. He will be assuming the position of Assistant Professor at Boston University School of Medicine in the Department of Pharmacology and Experimental Therapeutics.
Margaret Distler & Dr. Abraham Palmer’s review of Glo1 and MG accepted for publication in Frontiers in Genetics
Margaret and Abe’s review article: “Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights” has been accepted for publication in Frontiers in Behavioral and Psychiatric Genetics. You can find the article here.